Factors Affecting Vascular Complications in Patients with Diabetes Mellitus: A Literature Review

Ida Widaningsih; Kusman Ibrahim; Nursiswati Nursiswati

doi:10.56303/jhnresearch.v4i1.373

Authors

Ida Widaningsih Master of Nursing Students, Universitas Padjadjaran, Bandung, Indonesia
Kusman Ibrahim Department of Surgical-Medical Nursing, Universitas Padjadjaran, Bandung, Indonesia
Nursiswati Nursiswati Department of Surgical-Medical Nursing, Universitas Padjadjaran, Bandung, Indonesia

Keywords:

Biomarkers, Diabetes Mellitus, Vascular Complications, Risk Factors, Hyperglycemia

Abstract

Vascular complications in patients with diabetes mellitus (DM) are a major cause of morbidity and mortality, presenting a considerable impact on quality of life and global health burden. Although diabetes management continues to improve, vascular complications remain a major challenge. It is important to understand the factors that influence these complications to support more effective prevention and management. To explore the factors influencing vascular complications in patients with DM. This study used a literature review method. Articles were searched through three major databases, namely CINAHL, PubMed, and Scopus, using keywords such as "vascular complications," "DM," and "factors affecting." Inclusion criteria included English-language articles published within the last ten years (2016–2025), in the form of original research relevant to vascular complications in patients with DM. Data were extracted manually using a table that included authors, objectives, design, samples, variables, and outcomes. Analysis was conducted using a qualitative descriptive approach to identify key themes. A total of 14 articles met the inclusion criteria. From the analysis, six main themes were obtained: biochemical factors and biomarkers, clinical factors, cardiometabolic risk factors, vascular structural and anatomical changes, molecular mechanisms, and prevalence of vascular complications. The results showed that high HbA1c levels, hypertension, diabetes duration of more than 10 years, and increased biomarkers such as Bisphenol A (BPA) significantly increased the risk of vascular complications. Vascular complications in patients with DM are multifactorial, involving complex interactions between biochemical, clinical, and molecular factors.

Downloads

Download data is not yet available.

References

Ong K, Stafford L, Mclaughlin S. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet [Internet]. 2023;402. Available from: https://doi.org/10.1016/S0140-6736(23)01301-6

Eades CE, Burrows KA, Andreeva R, Stansfield DR, Evans JMM. Prevalence of gestational diabetes in the United States and Canada: a systematic review and meta-analysis. BMC Pregnancy Childbirth [Internet]. 2024;24(1):204. Available from: https://doi.org/10.1186/s12884-024-06378-2

Kemenkes RI. Situasi Penyakit Kronis di Indonesia. [Internet]. 2019. Available from: https://pusdatin.kemkes.go.id/

Fung A, Irvine M, Ayub A, Ziabakhsh S, Amed S, Hursh BE. Evaluation of telephone and virtual visits for routine pediatric diabetes care during the COVID-19 pandemic. J Clin Transl Endocrinol [Internet]. 2020;22:Nourazari, S., Davis, S. R., Granovsky, R., Austin. Available from: https://www.sciencedirect.com/science/article/pii/S2214623720300910

Wang Y, Dilidaxi D, Wu Y, Sailike J, Sun X, Nabi X. Composite probiotics alleviate type 2 diabetes by regulating intestinal microbiota and inducing GLP-1 secretion in db/db mice. Biomed Pharmacother [Internet]. 2020;125:109914. Available from: https://www.sciencedirect.com/science/article/pii/S0753332220301049

Pénager C, Bardet P, Timsit J, Lepercq J. Determinants of the persistency of macrosomia and shoulder dystocia despite treatment of gestational diabetes mellitus. Heliyon [Internet]. 2020;6(4):e03756–e03756. Available from: https://www.sciencedirect.com/science/article/pii/S2405844020306010

Zhang J, Huang J, He X, Li N, Miao Y, Li B, et al. Ginkgo biloba extract 761 reduces vascular permeability of the ovary and improves the symptom of ovarian hyperstimulation syndrome in a rat model. Gynecol Endocrinol. 2022;38(2):170–5.

Ergun-Longmire B, Clemente E, Vining-Maravolo P, Roberts C, Buth K, Greydanus DE. Diabetes education in pediatrics: How to survive diabetes. Disease-a-Month [Internet]. 2021;67(8):101153. Available from: https://www.sciencedirect.com/science/article/pii/S0011502921000250

Becs G, Zarjou A, Agarwal A, Kovács KÉ, Becs Á, Nyitrai M, et al. Pharmacological induction of ferritin prevents osteoblastic transformation of smooth muscle cells. J Cell Mol Med. 2016;20(2):217–30.

Gao C, Fu Y, Li Y, Zhang X, Zhang L, Yu F, et al. Microsomal Prostaglandin E Synthase-1-Derived PGE2 Inhibits Vascular Smooth Muscle Cell Calcification. Arterioscler Thromb Vasc Biol. 2016;36(1):108–21.

van Koeverden ID, Scholtes VPW, den Ruijter HM, Hazenberg SCE, de Kleijn DP V, de Borst GJ. The Impact of Diabetes and Time on the Atherosclerotic Plaque and Cardiovascular Outcome in Patients Undergoing Iliofemoral Endarterectomy. Eur J Vasc Endovasc Surg [Internet]. 2019;57(6):832–41. Available from: https://www.sciencedirect.com/science/article/pii/S1078588418307925

Legdeur N, van der Lee SJ, de Wilde M, van der Lei J, Muller M, Maier AB, et al. The association of vascular disorders with incident dementia in different age groups. Alzheimers Res Ther [Internet]. 2019;11(1):N.PAG-N.PAG. Available from: http://10.0.4.162/s13195-019-0496-x

Maranta F, Cianfanelli L, Cianflone D. Glycaemic Control and Vascular Complications in Diabetes Mellitus Type 2. Adv Exp Med Biol. 2021;1307:129–52.

Coppola A, Luzi L, Montalcini T, Giustina A, Gazzaruso C. Role of structured individual patient education in the prevention of vascular complications in newly diagnosed type 2 diabetes: the INdividual Therapeutic Education in Newly Diagnosed type 2 diabetes (INTEND) randomized controlled trial. Endocrine. 2018 Apr;60(1):46–9.

Shah NK, Farber A, Kalish JA, Eslami MH, Sengupta A, Doros G, et al. Occurrence of “never events” after major open vascular surgery procedures. J Vasc Surg [Internet]. 2016;63(3):738-745.e28. Available from: https://www.sciencedirect.com/science/article/pii/S0741521415019758

Tommerdahl KL, Shapiro ALB, Nehus EJ, Bjornstad P. Early microvascular complications in type 1 and type 2 diabetes: recent developments and updates. Pediatr Nephrol [Internet]. 2022;37(1):79–93. Available from: https://doi.org/10.1007/s00467-021-05050-7

Nanayakkara N, Ranasinha S, Gadowski A. Age, age at diagnosis and diabetes duration are all associated with vascular complications in type 2 diabetes. J Diabetes Complicat [Internet]. 2018;32. Available from: https://doi.org/10.1016/j.jdiacomp.2017.11.009

Mohanraj N, Prasanth S, Rajapriya P, Vinothkumar G, Vinodhini VM, Janardhanan R, et al. Bisphenol A accelerates the vascular complications in patients with Type 2 diabetes mellitus through vascular calcification—a molecular approach. Int Arch Occup Environ Health [Internet]. 2023;96(9):1291–9. Available from: https://doi.org/10.1007/s00420-023-02007-1

Avate A, Rathod V. A Study on relation of Carotid Intima Media Thickness (CIMT) to various micro & macro-vascular complications of diabetes. J Cardiovasc Dis Res [Internet]. 2023;14(12):1919–22. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L2029426591&from=export%0Ahttp://dx.doi.org/10.48047/jcdr.2023.14.12.217

Russo MP, Grande-Ratti MF, Burgos MA, Molaro AA, Bonella MB. Prevalence of diabetes, epidemiological characteristics and vascular complications. Arch Cardiol Mex. 2023;93(1):30–6.

Govindarajan Venguidesvarane A, Jasmine A, Varadarajan S, Shriraam V, Muthuthandavan AR, Durai V, et al. Prevalence of Vascular Complications Among Type 2 Diabetic Patients in a Rural Health Center in South India. J Prim Care Community Health. 2020;11:2150132720959962.

Alaboud AF, Tourkmani AM, Alharbi TJ, Alobikan AH, Abdelhay O, Al Batal SM. Microvascular and macrovascular complications of type 2 diabetic mellitus in Central, Kingdom of Saudi Arabia. Saudi Med J [Internet]. 2016;37. Available from: https://doi.org/10.15537/smj.2016.12.17062

Li J, Chattopadhyay K, Xu M, Chen Y, Hu F, Chu J, et al. Prevalence and associated factors of vascular complications among inpatients with type 2 diabetes: A retrospective database study at a tertiary care department, Ningbo, China. PLoS One. 2020;15(6):e0235161.

Hafidh K, Malek R, Al-Rubeaan K, Kok A, Bayram F, Echtay A, et al. Prevalence and risk factors of vascular complications in type 2 diabetes mellitus: Results from discover Middle East and Africa cohort. Front Endocrinol (Lausanne). 2022;13:940309.

Shita NG, Muluneh EK. Predictors of blood glucose change and vascular complication of type 2 diabetes mellitus patients in Felege Hiwot Referral Hospital, North West Ethiopia. Sci Rep [Internet]. 2021;11(1):12974. Available from: https://doi.org/10.1038/s41598-021-92367-w

Swiatkiewicz I, Patel NT, Villarreal-Gonzalez M, Taub PR. Prevalence of diabetic cardiomyopathy in patients with type 2 diabetes in a large academic medical center. BMC Med [Internet]. 2024;22(1):195. Available from: https://doi.org/10.1186/s12916-024-03401-3

Gaborit B, Julla JB, Fournel J, Ancel P, Soghomonian A, Deprade C, et al. Fully automated epicardial adipose tissue volume quantification with deep learning and relationship with CAC score and micro/macrovascular complications in people living with type 2 diabetes: the multicenter EPIDIAB study. Cardiovasc Diabetol [Internet]. 2024;23(1):328. Available from: https://doi.org/10.1186/s12933-024-02411-y

Pan Y, Zhong S, Zhou K, Tian Z, Chen F, Liu Z, et al. Association between Diabetes Complications and the Triglyceride-Glucose Index in Hospitalized Patients with Type 2 Diabetes. J Diabetes Res. 2021;2021:1–6.

Vasudhevan AS, Sumathi DM, Selvakumar AKC, Rajabalaji. A Comparative Study of Mean Platelet Volume in Diabetic Population With and Without Vascular Complication. Indones J Med Lab Sci Technol. 2023;5(1):42–52.

Arnold S V, Khunti K, Tang F, Chen H, Cid-Ruzafa J, Cooper A, et al. Incidence rates and predictors of microvascular and macrovascular complications in patients with type 2 diabetes: Results from the longitudinal global discover study. Am Heart J. 2022 Jan;243:232–9.

Suo L, Liu C, Zhang QY, Yao M Di, Ma Y, Yao J, et al. METTL3-mediated N6-methyladenosine modification governs pericyte dysfunction during diabetes-induced retinal vascular complication. Theranostics. 2022;27(1):277–89.

Domingueti CP, Dusse LM, Carvalho Md LP, Gomes KB, Fernandes AP. Diabetes mellitus: the linkage between oxidative stress, inflammation, hypercoagulability and vascular complications. J Diabetes Complicat [Internet]. 2016;30. Available from: https://doi.org/10.1016/j.jdiacomp.2015.12.018

Akkus G, Sert M. Diabetic foot ulcers: A devastating complication of diabetes mellitus continues non-stop in spite of new medical treatment modalities. World J Diabetes. 2022;13(12):1106–21.

Zhang T-Y, Wang X-N, Kuang H-Y, Zhang Z-M, Xu C-Y, Zhao K-Q, et al. Association between all-cause mortality and vascular complications in U.S. adults with newly diagnosed type 2 diabetes (NHANES 1999–2018). Acta Diabetol [Internet]. 2024; Available from: https://doi.org/10.1007/s00592-024-02342-w

Natarajan R. Epigenetic mechanisms in diabetic vascular complications and metabolic memory: The 2020 Edwin Bierman Award Lecture. Diabetes [Internet]. 2021;70. Available from: https://doi.org/10.2337/dbi20-0030

Pan T, Li L, Wei Q, Wang Z, Zhang Q, Qian Y, et al. Endovascular Celiac Denervation for Glycemic Control in Patients with Type 2 Diabetes Mellitus. J Vasc Interv Radiol [Internet]. 2021; Available from: https://www.sciencedirect.com/science/article/pii/S1051044321012744

van Bussel EF, Richard E, Busschers WB, Steyerberg EW, van Gool WA, Moll van Charante EP, et al. A cardiovascular risk prediction model for older people: Development and validation in a primary care population. J Clin Hypertens (Greenwich). 2019 Aug;21(8):1145–52.

Offer A, Arnold M, Clarke R, Bennett D, Bowman L, Bulbulia R, et al. Assessment of Vascular Event Prevention and Cognitive Function Among Older Adults With Preexisting Vascular Disease or Diabetes: A Secondary Analysis of 3 Randomized Clinical Trials. JAMA Netw open. 2019 Mar;2(3):e190223.

Ling W, Huang Y, Huang Y-. M, Fan R-. R, Sui Y, Zhao H-. L. Global trend of diabetes mortality attributed to vascular complications, 2000–2016. Cardiovasc Diabetol [Internet]. 2020;19. Available from: https://doi.org/10.1186/s12933-020-01159-5

Tékus V, Horváth ÁI, Csekő K, Szabadfi K, Kovács-Valasek A, Dányádi B, et al. Protective effects of the novel amine-oxidase inhibitor multi-target drug SZV 1287 on streptozotocin-induced beta cell damage and diabetic complications in rats. Biomed Pharmacother [Internet]. 2021;134:111105. Available from: https://www.sciencedirect.com/science/article/pii/S0753332220312981

Graves LE, Donaghue KC. Management of diabetes complications in youth. Ther Adv Endocrinol Metab [Internet]. 2019;10:2042018819863226–2042018819863226. Available from: https://doi.org/10.1177/2042018819863226

Raja P, Maxwell AP, Brazil DP. The Potential of Albuminuria as a Biomarker of Diabetic Complications. Cardiovasc Drugs Ther [Internet]. 2021;35(3):455–66. Available from: https://doi.org/10.1007/s10557-020-07035-4

Roque D, Ferreira J, Monteiro S, Costa M, Gil V. Understanding a woman’s heart: Lessons from 14 177 women with acute coronary syndrome. Rev Port Cardiol [Internet]. 2020;39(2):57–72. Available from: https://www.sciencedirect.com/science/article/pii/S0870255120300858

Scott ES, Januszewski AS, O’Connell R, Fulcher G, Scott R, Kesaniemi A, et al. Long-term glycemic variability and vascular complications in type 2 diabetes: post hoc analysis of the FIELD study. J Clin Endocrinol Metab [Internet]. 2020;105. Available from: https://doi.org/10.1210/clinem/dgaa361

Roque D, Ferreira J, Monteiro S, Costa M, Gil V. Understanding a woman’s heart: Lessons from 14 177 women with acute coronary syndrome. Rev Port Cardiol (English Ed [Internet]. 2020;39(2):57–72. Available from: https://www.sciencedirect.com/science/article/pii/S2174204920301331

Shao C, Wang J, Tian J, Tang Y. Coronary Artery Disease: From Mechanism to Clinical Practice BT - Coronary Artery Disease: Therapeutics and Drug Discovery. In: Wang M, editor. Singapore: Springer Singapore; 2020. p. 1–36. Available from: https://doi.org/10.1007/978-981-15-2517-9_1

Kunin A, Sargheini N, Birkenbihl C, Moiseeva N, Fröhlich H, Golubnitschaja O. Voice perturbations under the stress overload in young individuals: phenotyping and suboptimal health as predictors for cascading pathologies. EPMA J [Internet]. 2020;11(4):517–27. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85095994266&doi=10.1007%2Fs13167-020-00229-8&partnerID=40&md5=c1d677e877e83e19aaeb822e9e98c702

Maranta F, Cianfanelli L, Cianflone D. Glycaemic Control and Vascular Complications in Diabetes Mellitus Type 2 BT - Diabetes: from Research to Clinical Practice: Volume 4. In: Islam MS, editor. Cham: Springer International Publishing; 2021. p. 129–52. Available from: https://doi.org/10.1007/5584_2020_514

Greco M, Chiefari E, Accattato F, Corigliano DM, Arcidiacono B, Mirabelli M, et al. MicroRNA-1281 as a Novel Circulating Biomarker in Patients With Diabetic Retinopathy. Front Endocrinol (Lausanne). 2020;11:528.